Apr 30 2024 |
This Week in 340B: April 23 – April 29, 2024 |
McDermott Will & Schulte LLP |
Apr 30 2024 |
Mixed Algae Conversion Research Opportunity Will Award up to $18.8 Million to Address R&D Challenges in Converting Algae to Biofuels and Bioproducts |
Bergeson & Campbell, P.C. |
Apr 30 2024 |
It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices Has Arrived |
Epstein Becker & Green, P.C. |
Apr 30 2024 |
FSIS Declares Salmonella an Adulterant in Chicken Products |
Keller and Heckman LLP |
Apr 30 2024 |
Will California’s Proposed Acrylamide Warning Amendment Under Proposition 65 Pass Legal Muster? |
ArentFox Schiff LLP |
Apr 30 2024 |
2024 Florida Alcoholic Beverage Legislation Recap |
Jones Walker LLP |
Apr 29 2024 |
Crack Open a Cold One: The Future and Legal Considerations for Hemp Beverages |
Norris McLaughlin P.A. |
Apr 29 2024 |
Do Patent Claims to Methods of Treatment Cover In Vivo Transformations? |
Mintz |
Apr 29 2024 |
100% Pure, Natural False Advertising Litigation |
Katten |
Apr 29 2024 |
Cancer Drugs: Strategies For Patenting Antibody-Drug Conjugate Inventions |
Foley & Lardner LLP |
Apr 29 2024 |
Power Play or Fair Play? 21 Attorneys General Call for Prohibition of Intoxicating Hemp as Industry Faces Existential Threat |
Bradley Arant Boult Cummings LLP |
Apr 26 2024 |
Chili Competition: Momofuku No Longer Enforcing ‘CHILE CRUNCH’ Trademark |
Norris McLaughlin P.A. |
Apr 26 2024 |
USDA Publishes Final Rule on School Meals |
Keller and Heckman LLP |
Apr 25 2024 |
Germany Posts Information on Dossier Submitter’s Ongoing Role in Proposed REACH Restriction for PFAS |
Bergeson & Campbell, P.C. |
Apr 25 2024 |
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B |
McDermott Will & Schulte LLP |
Apr 25 2024 |
Florida DOR Proposes Update to Agricultural Real Property Appraisal Guidelines |
Jones Walker LLP |
Apr 25 2024 |
Federal Circuit Affirms Obviousness of Rifaximin Polymorph Patents and Denial of Motion to Modify Judgment After Post-Trial Patented Indication Carve Out |
Mintz |
Apr 25 2024 |
FTC Moves to Strike Most Noncompetes: Considerations for Cannabis Companies |
Bradley Arant Boult Cummings LLP |
Apr 25 2024 |
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers |
Foley & Lardner LLP |
Apr 25 2024 |
Utility of Consortia Advocacy — A Conversation with Heather J. Blankinship [Podcast] |
Bergeson & Campbell, P.C. |
Apr 25 2024 |
Florida's Division of Alcoholic Beverages and Tobacco Posts 2023 Quota Lottery Winners List |
Jones Walker LLP |
Apr 24 2024 |
New York’s New Alcohol Beverage Control Law Amendments Affect State Liquor License Applicants |
Greenberg Traurig, LLP |
Apr 24 2024 |
FDA Continues to Take Stance That it Will Not Issue CBD Rules |
Foley & Lardner LLP |
Apr 24 2024 |
Trending in Telehealth: March 26 – April 1, 2024 |
McDermott Will & Schulte LLP |
Apr 24 2024 |
Court Dismisses Lawsuit Targeting “All Natural” Claim |
Keller and Heckman LLP |
Apr 24 2024 |
This Week in 340B: April 16 – April 22, 2024 |
McDermott Will & Schulte LLP |
Apr 23 2024 |
EUON Welcomes New Study Proposals |
Bergeson & Campbell, P.C. |
Apr 23 2024 |
CMS Publishes Final Rules Implementing Part C and Part D Program Changes |
Mintz |
Apr 23 2024 |
Litigation Minute: The Lifecycle of Beauty Packaging |
K&L Gates LLP |
Apr 23 2024 |
AMS Publishes RFI on Electronic and Digital Link Disclosures Under the National Bioengineered Food Disclosure Standard |
Bergeson & Campbell, P.C. |
Apr 23 2024 |
A Greener World Asks FSIS to Seek Input on “Free Range” and “Pasture-Raised” Claims |
Keller and Heckman LLP |
Apr 22 2024 |
FDA Chief Says CBD Is Not NBD, Urges Congressional Action |
Bradley Arant Boult Cummings LLP |
Apr 22 2024 |
NY AG Launches Greenwashing Lawsuit Against Beef Producer |
Mintz |
Apr 21 2024 |
Off-Duty Conduct Protections for Employees’ 4/20 Celebrations: A Look at the High Points of a Few States’ Marijuana Laws |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 19 2024 |
HRSA Aims for Swift Dispute Resolution with new 340B ADR Final Rule |
Polsinelli PC |